Federal Judge Allows Collective Lawsuit Against Juul Marketing

Jun.30.2022
Federal Judge Allows Collective Lawsuit Against Juul Marketing
A US federal judge allows collective lawsuits against Juul, accusing the company of misleading marketing and demanding compensation for its purchasers.

A federal judge has permitted both adult and underage individuals who have purchased Juul e-cigarettes to file a collective lawsuit, demanding compensation from the company for deceptive marketing practices.

 

On Tuesday, U.S. District Judge William Orrick certified four groups, consisting of adults and minors both nationwide and in California, but rejected arguments made by Juul and its largest shareholder, tobacco giant Altria Group Inc., stating that the potential members of the collective were too diverse to bring a lawsuit for their claims together.

 

These class-action lawsuits do not accuse the product of causing bodily harm, but rather demand a refund of the money spent on purchasing Juul products.

 

The above is part of the multi-district litigation being handled by Orrick, which includes personal injury claims and lawsuits brought by local governments and school districts alleging that Juul fueled an epidemic of youth addiction.

 

Lawyers for plaintiffs Juul and Altria did not immediately respond to requests for comment.

 

The economic loss claims allege that Juul downplayed the addictive nature of its products and, had it not been for deceptive marketing, consumers would not have purchased these products or would have spent less money on them.

 

Juul argues that they should not be classified as a class-action lawsuit because different consumers were exposed to different advertisements, and some individuals became addicted while others did not.

 

However, Orrick believes that these differences are "largely immaterial under the legal theory being asserted.

 

Under pressure from regulators, Juul removed popular flavors such as mango and cucumber from retail stores in 2018 and closed its social media channels on Instagram and Facebook.

 

Earlier this month, the US Food and Drug Administration (FDA) ordered the removal of all Juul e-cigarettes from the market, but this decision was temporarily halted by the federal appeals court.

 

Juul has agreed to pay over $87 million to settle charges related to its marketing of products to minors with four states.

 

Source: Reuters

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Vietnam Decree 371: vaping and heated tobacco use fined up to $190
Vietnam Decree 371: vaping and heated tobacco use fined up to $190
Vietnam’s Government Decree 371, effective December 31, 2025, stipulates that users of e-cigarettes and heated tobacco products will be fined VND 3–5 million (about $114–$190) and required to destroy the products. The decree also provides that individuals who allow use at premises they own or manage will be fined VND 5–10 million (about $190–$380), with fines doubled for organizations.
Jan.04 by 2FIRSTS.ai
Malaysia MOH: 25,643 enforcement operations and 496,247 premises inspected nationwide as of Nov. 30
Malaysia MOH: 25,643 enforcement operations and 496,247 premises inspected nationwide as of Nov. 30
Malaysia’s Ministry of Health said it conducted 25,643 enforcement operations involving inspections of 496,247 premises nationwide as of Nov.
Jan.09 by 2FIRSTS.ai
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G said it plans to cancel all treasury shares it holds, totaling 10,866,189 shares, representing about 9.5% of shares outstanding, in line with Korea’s third amendment to the Commercial Act requiring companies to cancel repurchased shares within one year. The company also disclosed progress on its shareholder-return plan and multiple agenda items for next month’s shareholders meeting.
Feb.26
RJ Reynolds asks ITC to investigate alleged vape restriction violations by Heaven Gifts network
RJ Reynolds asks ITC to investigate alleged vape restriction violations by Heaven Gifts network
R.J. Reynolds Tobacco Co. has asked the U.S. International Trade Commission to open a Section 337 investigation into Heaven Gifts International — the umbrella company behind Elf Bars and Geek Bars — its subsidiaries and nine U.S. distributors.
Jan.16 by 2FIRSTS.ai
Product | Featuring a 1.47-inch TFT color display and up to 40W output, the Aspire Fluffi Pro launches in European channels.
Product | Featuring a 1.47-inch TFT color display and up to 40W output, the Aspire Fluffi Pro launches in European channels.
Aspire, a brand under Eigate Technology, has launched the open-system Fluffi Pro on its official website. It is now available via select online channels in Switzerland, Italy, and France at around €24.5, featuring upgrades over the standard Fluffi in power and battery capacity, screen configuration, high-wattage coil specs, and a redesigned side-fill/side-airflow structure.
Jan.13 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11